Please login to the form below

Not currently logged in
Email:
Password:

Vasella condemns ìhealthcare nationalismî

Novartis chief says governments favour local companies over multinationals

Novartis chief executive Daniel Vasella has criticised a rising trend of nationalism in the pharmaceutical sector, which he said was threatening economic efficiency, medical innovation and improved patient health.

Vasella told the Financial Times: ìWe are seeing healthcare nationalism coming back. From Japan to the US, it's all over the place.î

Recently, mergers in the sector have reflected governments' desire for national corporate champions. Ministers have shown their support for domestic industries by putting their weight behind local mergers.

Earlier this year, Germany's Bayer agreed to acquire local rival Schering AG while Novartis itself lost out in a bidding war for French firm, Aventis in 2004. In a highly politicised battle, the French government supported a rival offer from fellow French firm, Sanofi-Synthelabo.

Vasella, who is also president of the International Federation of Pharmaceutical Manufacturers and Associations, also criticised a 13 per cent price cut on hundreds of imported branded medicines imposed by the Polish government.

He said the move reflected ìgovernment pressure on multinational groups in favour of the promotion of local companiesî.

30th September 2008

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Flu
Influenza – the risk to vulnerable populations
Why we can't get complacent about flu vaccination...
dementia
Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
Data security
Concerns about data security are building a strong case for clinical mobility in EMEA
Electronic medical records have transformed the storage of sensitive information but how can the healthcare sector continue to protect patient and staff data?...